Clay Cauthen is a Cardiology physician. OpenAlex indexes 44 publications with 582 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1301 W 38th St
Suite 514
Austin, TX 787051000
Telephone
512-681-0500Provider last certified this registry record 14 May 2025.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20254 payments
- BridgeBio Pharma, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70%Beta blocker15.9%Carvedilol57%Metoprolol Succinate31%Metoprolol Tartrate12%Part D<11 patientsLoop diuretic10.1%Furosemide70%Torsemide30%Part D≥25 patients+ 9 more classes in this area
Metabolism & gastrointestinal
10.6%Potassium supplement7.6%Potassium Chloride100%Part D≥25 patientsSGLT2 inhibitor3%Farxiga100%Part D<11 patientsBlood & clotting
10.3%Factor Xa inhibitor7.9%Eliquis77%Xarelto23%Part D<11 patientsVitamin K antagonist1.4%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CCC-11212-ACC INCIDENCE OF SCAD IN A HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY PATIENT ON MAVACAMTEN
Journal of the American College of Cardiology
2026 - FULMINANT MYOCARDITIS IN THE SETTING OF ACUTE HIV AND GROUP A STREPTOCOCCUS PHARYNGITIS
Journal of the American College of Cardiology
2025 - CULTURE-NEGATIVE ENDOCARDITIS IN A PATIENT WITH RHEUMATOID ARTHRITIS AND A BIOPROSTHETIC VALVE
Journal of the American College of Cardiology
2025 - ASSOCIATION OF INSURANCE STATUS WITH FINANCIAL TOXICITY IN HEART FAILURE PATIENTS IN AN URBAN POPULATION IN THE UNITED STATES
Journal of the American College of Cardiology
2024 - CARDIAC REHABILITATION: TRENDS IN MEDICARE UTILIZATION AND REIMBURSEMENT
American Journal of Preventive Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”